Marimed (MRMD) Invested Capital (2011 - 2026)

Marimed (MRMD) has reported Invested Capital for 16 consecutive years, with $47.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital fell 22.3% year-over-year to $47.0 million in Q2 2026; TTM through Jun 2026 was $47.0 million, a 22.3% decrease from a year earlier, with the FY2025 full-year figure at $52.9 million, down 17.35% from the prior year.
• Invested Capital was $47.0 million for Q2 2026 at Marimed, down from $50.2 million in the prior quarter.
• Over five years, Invested Capital peaked at $116.6 million in Q2 2023 and troughed at $43.6 million in Q1 2022.
• A 5-year average of $69.6 million and a median of $63.4 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 143.23% in 2022 and sank 38.64% in 2024, its largest moves.
• Over 5 years, Invested Capital stood at $61.1 million in 2022, then rose by 14.25% to $69.8 million in 2023, then dropped by 8.26% to $64.0 million in 2024, then decreased by 17.35% to $52.9 million in 2025, then decreased by 11.15% to $47.0 million in 2026.
• The last three Invested Capital figures came in at $47.0 million (Q2 2026), $50.2 million (Q1 2026), and $52.9 million (Q4 2025), per Business Quant data.